the efficacy standard vertex is setting would seem to place combination therapy earlier in the developmental timetable for competitors, and the roche-intermune collaboration would have been a natural fit for just this. I wonder if vrtx will partner with someone, who it will be, and when?
Market Data 
Markets 
AI
